Stablecoin Development Corporation (SDEV)
NYSEAMERICAN: SDEV · Real-Time Price · USD
1.260
-0.050 (-3.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Stablecoin Development Employees
As of December 31, 2025, Stablecoin Development had 4 total employees, including 2 full-time and 2 part-time employees. The number of employees decreased by 10 or -71.43% compared to the previous year.
Employees
4
Change (1Y)
-10
Growth (1Y)
-71.43%
Revenue / Employee
n/a
Profits / Employee
-$5,535,250
Market Cap
33.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 390,000 |
| Johnson & Johnson | 138,200 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| TELA Bio | 209 |
| Pluri | 142 |
| Evaxion | 46 |
| NextCure | 40 |
SDEV News
- 22 days ago - Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV” - GlobeNewsWire
- 5 weeks ago - NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19% - Benzinga
- 5 weeks ago - NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update - GlobeNewsWire
- 6 weeks ago - Stablecoin Development Transcript: EGM 2026 - Transcripts
- 6 months ago - NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 7 months ago - NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - GlobeNewsWire
- 8 months ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 9 months ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire